Gersh Kuntzman, deputy politics editor at Newsweek, discusses President Trump's remarks on the Parkland school shooting that left 17 students and faculty members dead. President Trump made headlines when he failed to even use the word "gun" in his speech following the massacre.
Kuntzman says he doesn't believe anything will change with this latest shooting, at least not under the current administration and a Republican-controlled Congress.
The U.S. House of Representatives made history on Friday, after voting to pass a sweeping cannabis decriminalization and social equity bill.
Sen. Kelly Loeffler debated her Democratic opponent, Rev. Raphael Warnock, Sunday night, while challenger Jon Ossoff debated an empty podium when incumbent Sen. David Perdue refused to debate ahead of the January Senate runoffs in Georgia.
Joe LaVorgna, the chief economist for the White House National Economic Council, talked to Cheddar about the economy and the recently released jobs report'.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Biden stopped just short Thursday of the nationwide mandate he’s pushed before to stop the spread of the coronavirus.
Three former presidents say they’d be willing to publicly take a coronavirus vaccine, once one becomes available, to encourage all Americans to get inoculated against a disease that has already killed more than 273,000 people nationwide.
The U.S. has recorded over 3,100 COVID-19 deaths in a single day, obliterating the record set last spring.
The Senate on Thursday narrowly confirmed the nomination of Christopher Waller for the Federal Reserve’s Board of Governors, placing another of President Donald Trump’s picks on the Fed’s influential board after a string of high-profile rejections.
IBM security researchers say they have detected a cyberespionage effort that used targeted phishing emails to try to collect vital information associated with a U.N. initiative for distributing coronavirus vaccine to developing countries.
President-elect Joe Biden has swung behind a bipartisan COVID-19 relief effort. That comes as his top Capitol Hill allies cut their demands for a $2 trillion-plus measure by more than half.
